Literature DB >> 1723916

Prostacyclin activates tachykinin release from capsaicin-sensitive afferents in guinea-pig bronchi through a ruthenium red-sensitive pathway.

C E Mapp1, L M Fabbri, A Boniotti, C A Maggi.   

Abstract

1. We have investigated the ability of prostacyclin (PGI2) to contract guinea-pig isolated bronchi and the possible involvement of capsaicin-sensitive primary afferents in the response to PGI2. 2. PGI2 (0.1-100 microM) produced concentration-dependent contractions of the guinea-pig isolated bronchi. In vitro capsaicin desensitization (10 microM for 30 min followed by washing) significantly reduced the PGI2-induced contraction at all concentrations tested. A capsaicin-resistant component of contraction (40-60% of the overall response) was also evident. 3. Ruthenium red (3 microM), an inorganic dye which acts as a selective functional antagonist of capsaicin, significantly decreased PGI2-induced contractions, without affecting the response to substance P, neurokinin A or acetylcholine. 4. MEN 10, 207, (Tyr5, D-Trp6,8,9, Arg10)-neurokinin A (4-10) (3 microM), a selective antagonist of NK2-tachykinin receptors, significantly decreased PGI2-induced contractions and neurokinin A-induced contractions, without affecting the response to acetylcholine. 5. The effect of ruthenium red and MEN 10,207 on the one hand, and that of ruthenium red and capsaicin on the other was non additive. 6. These results indicate that PGI2-induced contraction of the guinea-pig isolated bronchi involves two distinct mechanisms, one of which involves transmitter (tachykinins) release from peripheral endings of capsaicin-sensitive primary afferents. In as much as PGI2-activation of primary afferents is sensitive to ruthenium red, we suggest that PGI2 shares a common mechanism of tachykinin release with that activated by capsaicin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1723916      PMCID: PMC1908289          DOI: 10.1111/j.1476-5381.1991.tb12383.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  Immunoblockade by a specific tachykinin antiserum of the non-cholinergic contractile responses in the guinea-pig isolated bronchus.

Authors:  C A Maggi; R Patacchini; P Baroldi; E Theodorsson; A Meli
Journal:  J Auton Pharmacol       Date:  1990-06

Review 2.  Capsaicin and primary afferent neurons: from basic science to human therapy?

Authors:  C A Maggi
Journal:  J Auton Nerv Syst       Date:  1991-04

3.  The effect of thiorphan and epithelium removal on contractions and tachykinin release produced by activation of capsaicin-sensitive afferents in the guinea-pig isolated bronchus.

Authors:  C A Maggi; R Patacchini; F Perretti; S Meini; S Manzini; P Santicioli; E Del Bianco; A Meli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990 Jan-Feb       Impact factor: 3.000

4.  Ruthenium red blocks the capsaicin-induced increase in intracellular calcium and activation of membrane currents in sensory neurones as well as the activation of peripheral nociceptors in vitro.

Authors:  A Dray; C A Forbes; G M Burgess
Journal:  Neurosci Lett       Date:  1990-03-02       Impact factor: 3.046

5.  A highly selective NK-2 tachykinin receptor antagonist containing D-tryptophan.

Authors:  P Rovero; V Pestellini; C A Maggi; R Patacchini; D Regoli; A Giachetti
Journal:  Eur J Pharmacol       Date:  1990-01-03       Impact factor: 4.432

6.  Reflex tracheal contraction evoked in dogs by bronchodilator prostaglandins E2 and I2.

Authors:  A M Roberts; H D Schultz; J F Green; D J Armstrong; M P Kaufman; H M Coleridge; J C Coleridge
Journal:  J Appl Physiol (1985)       Date:  1985-06

7.  Bronchial hyperreactivity to prostaglandin F 2 and histamine in patients with asthma.

Authors:  A A Mathé; P Hedqvist; A Holmgren; N Svanborg
Journal:  Br Med J       Date:  1973-01-27

8.  Sensitivity of the human cough reflex: effect of inflammatory mediators prostaglandin E2, bradykinin, and histamine.

Authors:  N B Choudry; R W Fuller; N B Pride
Journal:  Am Rev Respir Dis       Date:  1989-07

9.  Stimulation of pulmonary vagal afferent C-fibers by lung edema in dogs.

Authors:  A M Roberts; J Bhattacharya; H D Schultz; H M Coleridge; J C Coleridge
Journal:  Circ Res       Date:  1986-04       Impact factor: 17.367

10.  The 'efferent' function of capsaicin-sensitive nerves: ruthenium red discriminates between different mechanisms of activation.

Authors:  C A Maggi; R Patacchini; P Santicioli; S Giuliani; E Del Bianco; P Geppetti; A Meli
Journal:  Eur J Pharmacol       Date:  1989-11-07       Impact factor: 4.432

View more
  6 in total

1.  Indirect muscarinic receptor activation by pentamidine on airway smooth muscle.

Authors:  K Biyah; M Molimard; E Naline; B Bazelly; C Advenier
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  The endogenous cannabinoid agonist, anandamide stimulates sensory nerves in guinea-pig airways.

Authors:  R C Tucker; M Kagaya; C P Page; D Spina
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

Review 3.  Cardiac sympathetic afferent reflexes in heart failure.

Authors:  W Wang; R Ma
Journal:  Heart Fail Rev       Date:  2000-03       Impact factor: 4.214

4.  Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin.

Authors:  S Bevan; S Hothi; G Hughes; I F James; H P Rang; K Shah; C S Walpole; J C Yeats
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

5.  Effect of bradykinin and prostaglandins on the release of calcitonin gene-related peptide-like immunoreactivity from the rat spinal cord in vitro.

Authors:  L Andreeva; H P Rang
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

6.  Inhibition of [3H]resiniferatoxin binding to rat dorsal root ganglion membranes as a novel approach in evaluating compounds with capsaicin-like activity.

Authors:  A Szallasi; J Szolcsanyi; Z Szallasi; P M Blumberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-11       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.